April 20, 2026. Dynex Capital, Inc. misses on earnings expectations. Reported EPS is $0.31 EPS, expectations were $0 ...
Methodology that is not complete, as well as discrepancies regarding the proposed mode of action of lipoxin A4, are significant weaknesses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results